Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlated with a Poor Prognosis.
Francesco IovinoAnna DianaFrancesca CarlinoFranca FerraraccioGiuliano AntoniolFrancesca FisoneAlessandra PerroneFederica Zito MarinoIacopo PanareseMadhura S TathodeMichele CaragliaGianluca GattaRoberto RuggieroSimona ParisiFerdinando De VitaFortunato CiardielloLudovico DocimoMichele OrdituraPublished in: Journal of clinical medicine (2022)
In our series, high c-MET expression correlated with poor survival outcomes. Further studies are warranted to validate the clinical relevance and applicability of c-MET as a prognostic factor in ER+/HER2- early BC.